Visblog

UNIPORT Honours Wike, Names Convocation Arena After Him The University of Port Harcourt (UNIPORT), Rivers State has named its convocation Arena after the Minister of the Federal Capital Territory (FCT), Nyesom Wike. The arena, was officially inaugurated on Saturday by the Sole Administrator of Rivers State, Retired Vice Admiral Ibok-Ete Ekwe Ibas. The inauguration was part of activities marking the university’s 35 Combined Convocation Ceremony and 50th Anniversary. The Vice-Chancellor of the University, Prof. Owunari Georgewill, said that the first convocation of the university in 1982, was held in the old arena. “We are proud today, to celebrate the 35th convocation in our 50th year of existence in this fantastic edifice, built by the Rivers Government during Wike’s administration,” he said. Also, Ibas commended the contribution of Wike to the development of the institution. According to him, the conception and construction of the arena under Wike’s stewardship, reflects his enduring ...

Everybody pray for portable and wish him to Rip well as he challenges vdm for a f!ght. “Verydarkblackman" meet me for  boxing ring. Make we settle this like real men. I no be just artiste o, I be boxer wey never lose match before I nack Charles Okocha, Kizz Daniel Bodyguard and the last one Omo Igbo wey dem call Akpi,  say na juju I take run am when I cover him eye two seconds. Your Cho Cho Cho and big chest no fit intimidate me, if your mind reach make we run am -Senior Cruise Lord Portable dares Ratel president 

Buhari Never Looted Nigeria’s Treasury – Akpabio Defends Ex-President Senate President Godswill Akpabio praised the late former President Muhammadu Buhari, highlighting him as a leader who served Nigeria with integrity and did not exploit the country's treasury. Akpabio delivered the remarks on Thursday during an expanded Federal Executive Council meeting in Abuja, held to honor Buhari. The Senate President remarked that even the former president's critics would agree he did not misuse public funds during his tenure. He remarked, "Let's be honest; he was tough. He was a soldier who stood firm under fire, a leader who never shied away from responsibility, and most importantly, a Nigerian whose loyalty to this nation could not be bought." His resilience stemmed not from pride, but from a deep-seated patriotism—a fervent, unwavering conviction that Nigeria, despite its challenges, was still worth defending. However, some people do not share his view. "That is th...

The Abia State Agency for the Control of AIDS (ABSACA) has reported a significant drop in HIV prevalence from 5.1% in 2018 to 2.1% in 2024. The announcement was made by ABSACA Director General, Dr. Uloaku Ukaegbu, during a one-day sensitization workshop for Ward Development Committee (WDC) members in Umuahia, aimed at boosting community involvement in HIV prevention across the state’s 17 local government areas. Dr. Ukaegbu revealed that 46,788 individuals are currently receiving HIV treatment in Abia. However, she expressed concern over persistently high infection rates in areas like Ukwa East, Ikwuano, and Obingwa. She called on WDC members to lead grassroots campaigns, including town hall meetings, market outreaches, and faith-based engagements, to raise awareness about HIV prevention, testing, and treatment. Mr. Chinedu Iroh, ABSACA’s Monitoring and Evaluation Officer, emphasized prevention as the cornerstone of reducing HIV transmission. He urged sexually active individuals to use ...

The World Health Organization (WHO) welcomes the approval by the United States Food and Drug Administration (FDA) of injectable lenacapavir for HIV prevention. This milestone follows promising 2024 results from the PURPOSE 1 and  PURPOSE 2  trials, which demonstrated the safety and efficacy of lenacapavir across diverse populations and settings. Administered just twice a year, lenacapavir offers sustained protection and adds to the growing range of HIV prevention options. WHO currently recommends oral PrEP, the dapivirine vaginal ring, and long-acting injectable cabotegravir (CAB-LA) as options for HIV pre-exposure prophylaxis (PrEP). Lenacapavir’s discreet, long-acting formulation may help overcome key barriers such as daily pill burden, frequent clinic visits, and stigma associated with HIV prevention. “This regulatory milestone brings us one step closer to expanding access to an innovative HIV prevention option in lenacapavir,”   said Dr Meg Doherty...